Quidelortho CORP Form 4 insider transactions

QuidelOrtho Corporation's Chief Financial Officer, Joseph M. Busky, increased his direct beneficial ownership of common stock by 11,484 shares after the vesting of 21,367 restricted stock units, with 9,883 shares withheld for tax obligations.

QuidelOrtho Corp's Chief Operations Officer, Philip D. McLellan, reported the vesting of 4,749 restricted stock units and the subsequent disposition of 1,951 shares to cover tax obligations on June 30, 2025.

QuidelOrtho Corp. Director Ann D. Rhoads has filed an amended Form 4 to correct the vesting schedule for restricted stock units granted on May 29, 2025.

QuidelOrtho Corporation's Chief Financial Officer, Joseph M. Busky, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations, as detailed in a recent SEC Form 4 filing.

QuidelOrtho Corp Director Mary Lake Polan, Ph.D., reported the acquisition of 10,999 Restricted Stock Units through equity grants and conversion of deferred compensation, as detailed in a recent SEC Form 4 filing.

QuidelOrtho Corp Director Kenneth F. Buechler has acquired 13,803 Restricted Stock Units through a combination of equity grants and conversions in lieu of cash compensation, aligning his interests with shareholders.

QuidelOrtho Corp Director R. Scott Huennekens was granted 6,829 restricted stock units on May 29, 2025, which are scheduled to vest on May 29, 2026.

QuidelOrtho Corp Director John R. Chiminski reported the acquisition of 9,755 restricted stock units (RSUs) through equity grants and conversion of cash compensation, aligning his interests with shareholders.

QuidelOrtho Corp (QDEL) director Joseph D. Wilkins Jr. was granted 6,829 Restricted Stock Units (RSUs) on May 29, 2025, which are set to vest on May 29, 2026.

QuidelOrtho Corp. Director Kenneth J. Widder was granted and converted a total of 10,633 Restricted Stock Units (RSUs) on May 29, 2025, as part of his compensation for Board service.

QuidelOrtho Corp (QDEL) Director Evelyn S. Dilsaver was granted 6,829 restricted stock units (RSUs) on May 29, 2025, aligning her interests with shareholders.

QuidelOrtho Corporation's Director, Matthew Strobeck, was granted 6,829 restricted stock units on May 29, 2025, which are set to vest on May 29, 2026.

QuidelOrtho Corp Director Edward L. Michael has reported the acquisition of 10,535 restricted stock units, including grants and units received in lieu of cash compensation for board services.

Ann D. Rhoads, a Director at QuidelOrtho Corp, was granted a total of 8,780 Restricted Stock Units (RSUs) on May 29, 2025, as part of her compensation and deferred fee arrangements.

QuidelOrtho Corp Director Ann D. Rhoads has increased her beneficial ownership of common stock by 655 shares through the conversion of restricted stock units.

QuidelOrtho Corp Director Evelyn S. Dilsaver acquired 482 shares of common stock on May 24, 2025, through the release of restricted stock units as part of a deferred compensation program, increasing her total beneficial ownership to 10,624 shares.

Michelle A. Hodges, Chief Legal Officer of QuidelOrtho Corp, reported the acquisition of 420 common shares from restricted stock unit vesting and the subsequent disposition of 214 shares for tax obligations.

QuidelOrtho Corp's Chief Operations Officer, Philip D. McLellan, reported the vesting of restricted stock units and a subsequent disposition of shares to cover tax withholding obligations.

QuidelOrtho Corporation Director Joseph D. Wilkins Jr. reported the acquisition of 4,929 shares of common stock on May 22, 2025, resulting from the vesting of previously granted restricted stock units.

QuidelOrtho Corp Director Kenneth J. Widder converted 4,929 restricted stock units into common shares on May 22, 2025, increasing his direct beneficial ownership of common stock to 34,066 shares.

QuidelOrtho Corp Director Matthew Strobeck acquired 4,929 shares of common stock on May 22, 2025, through the vesting of restricted stock units, increasing his direct beneficial ownership to 17,775 shares.

QuidelOrtho Corp. Director Ann D. Rhoads acquired 4,929 shares of common stock on May 22, 2025, through the vesting of restricted stock units, increasing her direct beneficial ownership to 13,616 shares.

QuidelOrtho Corp Director Mary Lake Polan, Ph.D., has acquired 4,929 shares of common stock through the vesting of restricted stock units, increasing her direct beneficial ownership.

QuidelOrtho Corp (QDEL) Director Edward L. Michael reported the vesting of 4,929 restricted stock units (RSUs) into common stock, increasing his direct beneficial ownership to 21,352 shares.

QuidelOrtho Corporation's Director, R. Scott Huennekens, increased his beneficial ownership by 2,523 shares of common stock following the vesting of restricted stock units on May 22, 2025.

QuidelOrtho Corp Director Evelyn S. Dilsaver acquired 4,929 shares of common stock on May 22, 2025, through the vesting of restricted stock units, increasing her direct beneficial ownership to 10,142 shares.

QuidelOrtho Corp Director John R. Chiminski has reported the vesting of 2,523 restricted stock units, converting into common stock, as disclosed in a recent SEC Form 4 filing.

QuidelOrtho Director Kenneth F. Buechler has converted 4,929 restricted stock units into common shares, increasing his direct beneficial ownership to 92,706 shares.

Director Ann D. Rhoads reports the release of restricted stock units into QuidelOrtho common stock on May 18, 2025, through a deferred compensation program.

Director Edward L. Michael reports the release of restricted stock units resulting in changes to his beneficial ownership of QuidelOrtho Corp shares.